4-186082524-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003265.3(TLR3):​c.838G>A​(p.Asp280Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000957 in 1,614,126 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0050 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 4 hom. )

Consequence

TLR3
NM_003265.3 missense

Scores

2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.92

Publications

5 publications found
Variant links:
Genes affected
TLR3 (HGNC:11849): (toll like receptor 3) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. It thus plays a role in host defense against multiple viruses. [provided by RefSeq, Jul 2021]
TLR3 Gene-Disease associations (from GenCC):
  • immunodeficiency 83, susceptibility to viral infections
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0122540295).
BP6
Variant 4-186082524-G-A is Benign according to our data. Variant chr4-186082524-G-A is described in ClinVar as Benign. ClinVar VariationId is 537926.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00503 (766/152250) while in subpopulation AFR AF = 0.0173 (717/41544). AF 95% confidence interval is 0.0162. There are 6 homozygotes in GnomAd4. There are 400 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003265.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR3
NM_003265.3
MANE Select
c.838G>Ap.Asp280Asn
missense
Exon 4 of 5NP_003256.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR3
ENST00000296795.8
TSL:1 MANE Select
c.838G>Ap.Asp280Asn
missense
Exon 4 of 5ENSP00000296795.3
TLR3
ENST00000512264.1
TSL:1
c.7G>Ap.Asp3Asn
missense
Exon 1 of 2ENSP00000513668.1
TLR3
ENST00000513189.1
TSL:1
n.838G>A
non_coding_transcript_exon
Exon 4 of 5ENSP00000423386.1

Frequencies

GnomAD3 genomes
AF:
0.00501
AC:
762
AN:
152132
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0172
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00131
AC:
329
AN:
251446
AF XY:
0.000971
show subpopulations
Gnomad AFR exome
AF:
0.0180
Gnomad AMR exome
AF:
0.000838
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000532
AC:
778
AN:
1461876
Hom.:
4
Cov.:
37
AF XY:
0.000451
AC XY:
328
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0183
AC:
614
AN:
33480
American (AMR)
AF:
0.000939
AC:
42
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000243
AC:
27
AN:
1112002
Other (OTH)
AF:
0.00152
AC:
92
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00503
AC:
766
AN:
152250
Hom.:
6
Cov.:
32
AF XY:
0.00537
AC XY:
400
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0173
AC:
717
AN:
41544
American (AMR)
AF:
0.00203
AC:
31
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10590
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68028
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
39
78
117
156
195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00228
Hom.:
2
Bravo
AF:
0.00617
ESP6500AA
AF:
0.0168
AC:
74
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00163
AC:
198
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
15
DANN
Benign
0.96
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.49
Eigen_PC
Benign
-0.43
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.87
D
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.79
T
MutationAssessor
Benign
1.9
L
PhyloP100
2.9
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-2.4
N
REVEL
Benign
0.17
Sift
Benign
0.21
T
Sift4G
Benign
0.22
T
Polyphen
0.27
B
Vest4
0.12
MVP
0.84
MPC
0.18
ClinPred
0.028
T
GERP RS
2.7
Varity_R
0.21
gMVP
0.61
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112077022; hg19: chr4-187003678; COSMIC: COSV99031787; API